Expanding access to long-term allergy relief

Allergies and asthma remain two of the most prevalent chronic diseases in America, impacting more than 60 million people every year. A large number of these correspond to airborne allergens, such as tree, grass, and weed pollen, dust, molds, and pet dander, which vary by environment and geographical region. They can trigger a range of symptoms, from skin irritation, runny and stuffy nose, and itchy and watery eyes to sinus infections and, in extreme cases, anaphylaxis. On a national scale, allergies regularly lead to loss of work and school days and an economic cost in the billions of dollars. Yet, with limited access to specialist care, and with many allergy sufferers either misdiagnosing their symptoms or opting for over-the-counter medication, only one in five is eventually seen by a specialist1. The fact is, allergy care is primary care. Not only can long-term relief from allergies drastically improve a person’s quality of life – allergy care also serves as a preventive measure, with childhood allergies directly related to the onset of conditions such as allergic asthma. Its diagnosis and treatment benefit directly from the attention and continuity of care that only a primary care physician can deliver. Our mission is to support providers in this effort. Allergen immunotherapy is a long-term treatment for allergies that is proven to be safe and effective. As a leader in the allergen immunotherapy industry, United Allergy Services has the expertise, reach, and infrastructure necessary to support our providers as they deliver to their patients the gold standard in allergy care. Read more about what we do by clicking HERE. 1Immunotherapy Can Provide Lasting Relief”, American Academy of Allergy, Asthma & Immunology, 2019